CN106620048A - Traditional Chinese medicine composition for treating heart disease - Google Patents
Traditional Chinese medicine composition for treating heart disease Download PDFInfo
- Publication number
- CN106620048A CN106620048A CN201510731650.8A CN201510731650A CN106620048A CN 106620048 A CN106620048 A CN 106620048A CN 201510731650 A CN201510731650 A CN 201510731650A CN 106620048 A CN106620048 A CN 106620048A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- traditional chinese
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating heart disease. The traditional Chinese medicine composition is obtained by crushing tuber fleeceflower stem, albizia bark, wide peach kernel, spine date seed, solidago virgaurea, safflower, Styrax, ginkgo biloba, root of kudzu vine, Ligusticum wallichii, Yedo violet, potentilla kleiniana Wight etArn, and pubescent holly root, and mixing and stirring the materials. The various traditional Chinese medicines are subjected to reasonable and scientific compatibility, through a lot of clinical verification, a prescription selects natural Chinese herbal medicines, no side effect and uncomfortable reaction are generated during usage, the traditional Chinese medicine composition has the efficacy for tranquilizing, eliminating vexation and dredging vessels, activating blood circulation to dissipate blood stasis, and activating collaterals, a preparation method is simple, the raw materials are easily available, curative effect is good, effectiveness is fast, and cost is low.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicines, and in particular to one kind treats cardiopathic Chinese medicine composition.
Background technology
Heart is human body " engine ", once cardiac arrest and pass through rescue and be unable to rebeating, that is just meaned
, the life of a people is terminated, and heart disease is the number one killer of human health, the people in the whole world 1/3
Mouth is dead because heart disease causes, and China, there is hundreds of thousands people to die from heart disease every year.Angiocardiopathy
The reason for generation is considerably complicated, but it has been investigated that psychological factor is played and can not neglected to cardiopathic generation
Depending on effect, that is long-term negative feeling repeatedly, occupy an important position in cardiopathic generation.
Some scholars did zoopery, and an electrode is imbedded at the emotional center position in white mouse brain, and Stimulation of The Brain is thin
Born of the same parents just cause defensive reaction, white mouse to hide in corner, cuddle up in a heap.So after continued stimulus 3-4 hours,
Just there is significantly imbalance in the body of mouse:Blood pressure is raised, and heart rate, respiratory rate change.What is more,
At similar conditions, there is serious heart failure, or blood vessel obstruction in some animals.As can be seen here, tightly
If the emotional distress opened is changed into long-term from temporary transient, will make body that a series of changes, the such as rhythm of the heart occur not
Together, so that the angiocardiopathy such as the Gao Xue village, coronary heart disease, it can be said that heart disease is in current people's life
A kind of common disease, frequently-occurring disease.At present, it is used to treat cardiopathic Chinese medicine composition and method very on market
It is many, but be primarily directed to characteristic of disease shape to varying degrees and treat, therefore have certain limitation.
The content of the invention
According to above-mentioned elaboration, it is an object of the invention to provide having centering of calming the nerves, relieving restlessness dredging vascellum is living
Blood stagnation resolvation, one kind for the efficiency that proceeds blood cycle treats cardiopathic Chinese medicine composition.
The technical scheme that the present invention is provided:One kind treats cardiopathic Chinese medicine composition, is by following weight portion
Raw material make:
20~25 parts of Polygonum multiflower knotweed, 25~30 parts of cortex albiziae, wild 7~10 parts of peach kernel, 15~20 parts of yncaria stem with hooks,
6~9 parts of Semen Platycladi, 7~10 parts of spina date seed, 6~10 parts of goldenrod, 5~7 parts of safflower, storax 3~
5 parts, 4~6 parts of ginkgo leaf, 20~25 parts of the root of kudzu vine, 9~12 parts of Ligusticum wallichii, 9~12 parts of Chinese violet, snake
Containing 6~9 parts, 15~25 parts of RADIX ILICIS PUBESCENTIS.
Preparation method is:The raw material of the weight portion is carried out respectively disinfection by ultraviolet light, is crushed respectively, filter screen
100-300 mesh sieves are crossed into herb powder, carry out mixing.
Other optimization formulas of the invention are constituted in embodiment.
Composition described above be by weight as proportioning, if be intended for single use, can proportionally, according to tradition
It is edible after the traditional Chinese medical science is fried;If can increase according to corresponding proportion during batch production or reduce, such as mass produce
Can by kilogram in units of, or in units of ton, small-scale production can also be in units of milligram, and weight can
To increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.
The ratio of above weight proportion is obtained through science screening, for especial patient, such as severe or light
Disease, the patient of fat or slight of stature, can accordingly adjust the proportioning of the amount of composition, increase or decrease and be less than
100%, drug effect is constant.
Chinese medicine material in composition described above, especially adjutant with allow medicine with appropriate with the identical property of medicine
Chinese medicine is replaced, and its medicine effect of the Chinese medicine preparation after replacement is constant.
Chinese medicine material in composition described above, it is also possible to which Chinese medicine is prepared into according to existing galenic pharmacy, pharmacy principle
Preparation, the i.e. Chinese medicine material by the way that above-mentioned formula is constituted are processed through extraction or other modes, make medicine
Active material, subsequently, with the material as raw material, adds pharmaceutically acceptable carrier, according to preparation when needing
Made by routine techniques.The active material can be obtained by extracting Chinese medicine material respectively, it is also possible to
Obtained by the common Chinese medicine material that extracts, it is also possible to obtain by other means, such as:By crushing, squeezing,
Calcine, grind, sieving, extracting, water extraction, alcohol extracting, ester is carried, ketone is carried, chromatographed etc., and method obtains, these
Active material can be the material of medicinal extract form, can be dry extract can also be liquid extract, according to preparation
Difference needs to determine to make different concentration.
The pharmaceutical composition of the medicine present invention of the present invention, its pharmaceutically active substance is obtained through extracting processing
, processing can adopt any combinations in said method.
The various drug matchings of the present invention are reasonable, science, and a large amount of clinical verifications of Jing, prescription configuration is all taken from
Natural Chinese medicinal herb, reaction without any side effects and uncomfortable in use, with centering of calming the nerves, relieving restlessness dredging blood
Pipe, promoting blood circulation and removing blood stasis, the effect of proceeding blood cycle, its preparation method is simple, and raw material is easy to get, and good effect, sees
Effect is fast, low cost.
Specific embodiment
Technical scheme is clearly and completely described below, it is clear that described embodiment
Only a part of embodiment of the invention, rather than the embodiment of whole.Based on the embodiment in the present invention,
The every other embodiment that those of ordinary skill in the art are obtained under the premise of creative work is not made,
Belong to the scope of protection of the invention.
Rationally, its compatibility principle is the compatibility of drugs of the present invention:
The present invention discloses following examples.
Embodiment 1:
One kind treats cardiopathic Chinese medicine composition, is to be prepared by the raw materials in:
20 parts of Polygonum multiflower knotweed, 25 parts of cortex albiziae, wild 7 parts of peach kernel, 15 parts of yncaria stem with hooks, 6 parts of Semen Platycladi, wild jujube
7 parts of benevolence, 6 parts of goldenrod, 5 parts of safflower, 3 parts of storax, 4 parts of ginkgo leaf, 20 parts of the root of kudzu vine, river
9 parts of rhizome of chuanxiong, 12 parts of Chinese violet, snake contain 6 parts, 15 parts of RADIX ILICIS PUBESCENTIS.
Preparation method is:The raw material of the weight portion is carried out respectively disinfection by ultraviolet light, is crushed respectively, filter screen
150 mesh sieves are crossed into herb powder, carry out mixing.
Embodiment 2:
One kind treats cardiopathic Chinese medicine composition, is to be prepared by the raw materials in:
25 parts of Polygonum multiflower knotweed, 30 parts of cortex albiziae, wild 9 parts of peach kernel, 20 parts of yncaria stem with hooks, 8 parts of Semen Platycladi, wild jujube
7 parts of benevolence, 10 parts of goldenrod, 7 parts of safflower, 7 parts of storax, 6 parts of ginkgo leaf, 25 parts of the root of kudzu vine,
12 parts of Ligusticum wallichii, 10 parts of Chinese violet, snake contain 8 parts, 25 parts of RADIX ILICIS PUBESCENTIS.
Preparation method is:The raw material of the weight portion is carried out respectively disinfection by ultraviolet light, is crushed respectively, filter screen
300 mesh sieves are crossed into herb powder, carry out mixing.
Embodiment 3:
One kind treats cardiopathic Chinese medicine composition, is to be prepared by the raw materials in:
25 parts of Polygonum multiflower knotweed, 30 parts of cortex albiziae, wild 10 parts of peach kernel, 15 parts of yncaria stem with hooks, 9 parts of Semen Platycladi, acid
10 parts of jujube kernel, 10 parts of goldenrod, 5 parts of safflower, 7 parts of storax, 6 parts of ginkgo leaf, 20 parts of the root of kudzu vine,
12 parts of Ligusticum wallichii, 12 parts of Chinese violet, snake contain 8 parts, 25 parts of RADIX ILICIS PUBESCENTIS.
Preparation method is:The raw material of the weight portion is carried out respectively disinfection by ultraviolet light, is crushed respectively, filter screen
200 mesh sieves are crossed into herb powder, carry out mixing.
The present invention consists of the wild Chinese patent drug without any toxicity, has no toxic side effect, and proterties is dark brown powder,
It is such as fried rear for brown soup.
Points for attention when using are:Diet radish during medication, pungent, fish raw meat, leek.
To show the application effect of the present invention, Jing clinical and experimental studies of the present invention are proved:
1st, certain man, heart disease slightly shies crazy pent-up, and continuous use three weeks, symptom disappears.
2nd, certain man, heart disease of being poisoned is fully recovered after medication after four weeks.
The above, the only specific embodiment of the present invention, but protection scope of the present invention is not limited to
This, any those familiar with the art the invention discloses technical scope in, can readily occur in
Change or replacement, all should be included within the scope of the present invention.Therefore, protection scope of the present invention should
It is described to be defined by scope of the claims.
Claims (1)
1. one kind treats cardiopathic Chinese medicine composition, it is characterised in that:It is by the raw material system of following weight portion
Into:
20~25 parts of Polygonum multiflower knotweed, 25~30 parts of cortex albiziae, wild 7~10 parts of peach kernel, 15~20 parts of yncaria stem with hooks,
6~9 parts of Semen Platycladi, 7~10 parts of spina date seed, 6~10 parts of goldenrod, 5~7 parts of safflower, storax 3~
5 parts, 4~6 parts of ginkgo leaf, 20~25 parts of the root of kudzu vine, 9~12 parts of Ligusticum wallichii, 9~12 parts of Chinese violet, snake
Containing 6~9 parts, 15~25 parts of RADIX ILICIS PUBESCENTIS;
Preparation method is:The raw material of the weight portion is carried out respectively disinfection by ultraviolet light, is crushed respectively, filter screen
100-300 mesh sieves are crossed into herb powder, carry out mixing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510731650.8A CN106620048A (en) | 2015-11-03 | 2015-11-03 | Traditional Chinese medicine composition for treating heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510731650.8A CN106620048A (en) | 2015-11-03 | 2015-11-03 | Traditional Chinese medicine composition for treating heart disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106620048A true CN106620048A (en) | 2017-05-10 |
Family
ID=58809885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510731650.8A Pending CN106620048A (en) | 2015-11-03 | 2015-11-03 | Traditional Chinese medicine composition for treating heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106620048A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101711850A (en) * | 2009-10-26 | 2010-05-26 | 泰一和浦(北京)中医药研究院有限公司 | Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method |
CN103550688A (en) * | 2013-10-26 | 2014-02-05 | 荣成市科学技术情报研究所 | Traditional Chinese medicine (TCM) composition for treating palpitation |
CN104547973A (en) * | 2013-10-15 | 2015-04-29 | 青岛博研达工业技术研究所(普通合伙) | Health traditional Chinese medicine for treating chest obstruction and preparation method thereof |
-
2015
- 2015-11-03 CN CN201510731650.8A patent/CN106620048A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101711850A (en) * | 2009-10-26 | 2010-05-26 | 泰一和浦(北京)中医药研究院有限公司 | Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method |
CN104547973A (en) * | 2013-10-15 | 2015-04-29 | 青岛博研达工业技术研究所(普通合伙) | Health traditional Chinese medicine for treating chest obstruction and preparation method thereof |
CN103550688A (en) * | 2013-10-26 | 2014-02-05 | 荣成市科学技术情报研究所 | Traditional Chinese medicine (TCM) composition for treating palpitation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101513437B (en) | Antifatigue Chinese pharmaceutical composition and preparation method thereof | |
CN100528214C (en) | Capsule for treating epilepsia and its preparing method | |
CN1961926A (en) | Medicament for treating acne | |
CN1742775A (en) | Medicine composition for preventing and treating orthopedic diseases | |
CN104489172A (en) | Acanthopanax health tea for improving immunity and preparation method thereof | |
CN103977390B (en) | A kind of preparation method and its usage of ginger onion medicated wine composition | |
Orji et al. | Biochemical assessment of ethanol leaf extract of cnidoscolusaconitifoliuson liver integrity of albino rat treated with lead | |
CN106074710A (en) | A kind of medicine treating epilepsy | |
CN106620048A (en) | Traditional Chinese medicine composition for treating heart disease | |
CN106421572A (en) | Traditional Chinese medicine preparation for treating animal theileriosis and preparation method thereof | |
CN105727089A (en) | Application of medicine composition containing folium artemisiae argyi to preparing medicine for treating irritable bowel syndrome | |
CN107260780B (en) | Traditional Chinese medicine composition for treating rheumatic arthritis | |
CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
CN105031329A (en) | Traditional Chinese medicine preparation used for treating liver qi stagnation-type hemicranias, and preparation method thereof | |
CN105055924A (en) | Medicine preparation used for treating migraine | |
CN104116029B (en) | For the health food and preparation method thereof of develop immunitypty | |
CN103623109A (en) | Traditional Chinese medicine composition for treating ischemic cerebrovascular disease and preparation method thereof | |
CN103690771B (en) | Be used for the treatment of medicine of lamb colibacillosis and preparation method thereof | |
CN106074708A (en) | The application in preparation treatment AED of the general anesthesia element | |
CN1907315A (en) | Orthopaedics disease treating and preventing medicinal composition | |
CN104547695B (en) | It is a kind of for treating the pharmaceutical composition and its application of trigeminal neuralgia | |
CN103623351B (en) | Stroke rehabilitation revival pill and preparation method thereof | |
CN105343223A (en) | Traditional Chinese medicine for treating cerebral thrombosis and hemiplegia and preparation method of oral liquid preparation of traditional Chinese medicine | |
Bairagi et al. | Immune-Boosting Property of Ayurvedic Formulations | |
CN104147245B (en) | A kind of salsola collina composition, its preparation method and its application in Weight-lossing hypolipemic medicine is prepared |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |